Stocks You May Consider Buying From Fundamental Perspective: Since the Donald Trump administration’s April 2 “Liberation Day” announcements, Indian equity benchmark Nifty50 has gyrated in a range of more than 2,100 points, between 21,743.7 (April 7) and 23,872.4 (April 17). The wild swings on Dalal Street mirror the global trend as investors continue to track headlines about retaliatory action by America’s major trade partners, and so on, with rising concerns about the potential impact of the trade war on growth and delays in more reductions in COVID-era interest rates. As market participants take a pause with Dalal Street shut for the Good Friday holiday on April 18, it is an opportune time to plan additions or adjustments to your portfolio.
Here are a few stocks that analysts like fundamentally from a long-term perspective.
All images are representational. Image source: Pexels, PTI, AI
1/12Axis Direct has a 'buy' call on Mold-Tek Packaging shares with a target price of Rs 555 apiece.
As of April 17, the brokerage's target price suggests an upside of 8.5 per cent.
2/12Sharekhan has a 'buy' rating assigned to ICICI Lombard with a target price of Rs 2,300, which implies a potential upside of 28.3 per cent.
3/12
Geojit has a 'buy' call on Zydus Life shares with a target of Rs 975. The target suggests an upside of 17.3 per cent.
4/12Axis Direct has a 'buy' call on the stock with a target of Rs 1,201.
The target suggests an upside of 7.0 per cent, as of April 17.
5/12Axis Direct has a 'buy' rating assigned to InterGlobe Aviation with a target of Rs 5,800 per share.
The target suggests an upside of 8.1 per cent in the largecap airline stock.
6/12BOB Capital Markets has a 'buy' rating on ICICI Pru shares with a target of Rs 674. The target suggests a 13.2 per cent upside.
7/12IDBI Capital Markets has a 'buy' rating assigned to LIC Housing Finance shares with a target of Rs 688.
The target suggests upside potential of almost 14 per cent.
8/12Motilal Oswal Financial Services has a 'buy' rating on ABB shares with a target of Rs 6,700 apiece. The target implies upside of more than 20 per cent in the stock.
9/12BOB Capital Markets has a 'buy' rating assigned to Abbott shares with a target of Rs 35,292 apiece.
10/12ICICI Securities has a 'buy' call on Home First Finance shares with a target of Rs 1,350 apiece.
11/12Axis Direct has a 'buy' call on Jyothy Labs shares with a target of Rs 405 apiece, which indicates a potential upside of 7.8 per cent.
12/12ICICI Securities has a 'buy' rating assigned to Niva Bupa Health Insurance shares with a target price of Rs 90 apiece. The target suggests an upside of 18.7 per cent in the stock.